参考文献

参考文献

[1]Turkbey EB,Nacif MS,Guo M,et al.Prevalence and Correlates of Myocardial Scar in a US Cohor[tJ].JAMA,2015,314(18):1945-1954.

[2]全旭东.冠心病人非心脏手术的麻醉进展[J],中国麻醉与镇痛,2003,3:228-229.

[3]吴美华,柯益明,杨美珍.围手术期心肌梗死研究进展[J],中国老年学杂志,2014,4:1129-1132.

[4]Thygesen K,Alpert JS,White HD,et al.Universal definition of myocardial infarction[J].Circulation,2007,116(22):2634-2653.

[5]Das MK,Zipes DP.Fragmented QRS:a predictor of mortality and sudden cardiac death[J].Heart Rhythm,2009,6(3 Suppl):S8-14.

[6]Kristensen SD,Knuuti J,Saraste A,et al.2014 ESC/ESA Guidelines on non-cardiac surgery:cardiovascular assessment and management:The Joint Task Force on non-cardiac surgery:cardiovascular assessment and management of the European Society of Cardiology(ESC)and the European Society of Anaesthesiology(ESA)[J].Eur Heart J,2014,35(35):2383-2431.

[7]庄心良,曾因明,陈伯銮.现代麻醉学[M].3 版.北京:人民卫生出版社,2004.

[8]Murai T,Yonezawa Y,Doi Y,et al.Assessment of prognosis of old myocardial infarction[J].J Cardiol,1992,22(1):51-60.

[9]Sheth T,Chan M,Butler C,et al.Prognostic capabilities of coronary computed tomographic angiography before non-cardiac surgery:prospective cohort study[J].BMJ,2015,350:1907.

[10]Fleisher LA,Fleischmann KE,Auerbach AD,et al.2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery:executive summary:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guideline[sJ].Circulation,2014,130(24):2215-2245.

[11]Davis C,Tait G,Carroll J,et al.The Revised Cardiac Risk Index in the new millennium:a single-centre prospective cohort re-evaluation of the original variables in 9 519 consecutive elective surgical patient[sJ].Canadian Journal of Anesthesia/Journal canadien d'anesthésie,2013,60(9):855-863.

[12]Ford MK,Beattie WS,Wijeysundera DN.Systematic review:prediction of perioperative cardiac complications and mortality by the revised cardiac risk index[J].Ann Intern Med,2010,152(1):26-35.

[13]Bilimoria KY,Liu Y,Paruch JL,et al.Development and evaluation of the universal ACS NSQIP surgical risk calculator:a decision aid and informed consent tool for patients and surgeon[sJ].J Am Coll Surg,2013,217(5):833-842.e3.

[14]Dupuis JY,Wang F,Nathan H,et al.The cardiac anesthesia risk evaluation score:a clinically useful predictor of mortality and morbidity after cardiac surgery[J].Anesthesiology,2001,94(2):194-204.

[15]Nashef SA,Roques F,Sharples LD,et al.EuroSCORE I[IJ].Eur J Cardiothorac Surg,2012,41(4):734-744.

[16]Sinning C,Lillpopp L,Appelbaum S,et al.Angiographic score assessment improves cardiovascular risk prediction:the clinical value of SYNTAX and Gensini application[J].Clin Res Cardiol,2013,102(7):495-503.

[17]Tuttnauer A,Meroz Y,Landesberg G.Risk to and resilience of the coronary heart disease patient during surgery[J].Curr Opin Crit Care,2011,17(4):358-361.

[18]Rao TL,Jacobs KH,El-Etr AA.Reinfarction following anesthesia in patients with myocardial infarction[J].Anesthesiology,1983,59(6):499-505.

[19]Naughton C,Reilly N,Feneck R.Cardiac disease in the non-cardiac surgical population:effect on surviva[lJ].Br J Nurs,2005,14(13):718-724.

[20]Hillis LD,Smith PK,Anderson JL,et al.2011 ACCF/AHA guideline for coronary artery bypass graft surgery:executive summary:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guideline[sJ].J Thorac Cardiovasc Surg,2012,143(1):4-34.

[21]Levine GN,Bates ER,Blankenship JC,et al.2011 ACCF /AHA /SCAI Guideline for Percutaneous Coronary Intervention.A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Intervention[sJ].J Am Coll Cardiol,2011,58(24):e44-e122.

[22]Levine GN,Bates ER,Bittl JA,et al.2016 ACC /AHA Guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease:a report of the american college of cardiology/american heart association task force on clinical practice guideline[sJ].Circulation,2016,134(10):e123-e155.

[23]Stone JG,Foex P,Sear JW,et al.Myocardial ischemia in untreated hypertensive patients:effect of a single small oral dose of a betaadrenergic blocking agen[tJ].Anesthesiology,1988,68(4):495-500.

[24]Group PS,Devereaux PJ,Yang H,et al.Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery(POISE trial):a randomised controlled tria[lJ].Lancet,2008,371(9627):1839-1847.

[25]Mantz J,CMSamama,F.Tubach,et al.Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery:the multicentre,randomized,blinded,placebo-controlled,STRATAGEM tria[lJ].Br J Anaesth,2011,107(6):899-910.

[26]Jones C,Liban B.Perioperative use of dual antiplatelet therapy for patients with coronary artery stent[sJ].Br J Hosp Med(Lond),2009,70(2):117.

[27]Leslie K,Myles P,Devereaux P,et al.Neuraxial block,death and serious cardiovascular morbidity in the POISE tria[lJ].Br J Anaesth,2013,111(3):382-390.

[28]Yu CH,Beattie WS.The effects of volatile anesthetics on cardiac ischemic complications and mortality in CABG:a meta-analysi[sJ].Can J Anaesth,2006,53(9):906-918.

[29]Liu SS,Block BM,Wu CL.Effects of perioperative central neuraxial analgesia on outcome after coronary artery bypass surgery:a metaanalysi[sJ].Anesthesiology,2004,101(1):153-161.